Publications by authors named "Matthew Labriola"

Claim this Profile
G
Grief Among Oncology Providers: Prevalence and Association with Burnout.
Shannon R McGue, Cameron J Oswalt, Benjamin T Berger, Sarah S Morgan, Sara A Barlow, Matthew K Labriola

J Cancer Educ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic cerebellitis with Kelch-like protein 11 antibodies as an initial presentation for testicular seminoma.
Joshua S Mercer, Elisha Myers, Matthew K Labriola

BMJ Case Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.
Zeynep B Zengin, Nicholas C Henderson, Joseph J Park, Alicia Ali, Charles Nguyen, Matthew Labriola

Prostate Cancer Prostatic Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer.
Amanda Broderick, Elizabeth Pan, Jinju Li, Alec Chu, Clara Hwang, Matthew Labriola

Prostate Cancer Prostatic Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient engagement in designing and publishing research in prostate cancer: a scoping review.
Linda Sutton, Matthew Labriola, Thomas Bognanno, Shelby Moneer, Jennifer Ghith

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes.
Laura S Graham, Nicholas C Henderson, Olesia Kellezi, Clara Hwang, Pedro C Barata, Matthew Labriola

JCO Precis Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.
Joseph J Park, Alec Chu, Jinju Li, Alicia Ali, Rana R McKay, Matthew K Labriola

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for Designing and Implementing a Multi-institution Undergraduate Medical Education Experience.
Steven King, Emma Y Wu, Christine Lin, Matthew Labriola, Myles Nickolich

J Cancer Educ· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer.
Clara Hwang, Nicholas C Henderson, Shih-Chun Chu, Brandon Holland, Frank C Cackowski, Matthew Labriola

JAMA Netw Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration.
Tanya Dorff, Zeynep Zengin, Nicholas Henderson, Alicia Ali, Charles Nguyen, Matthew Labriola

Res Sq· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to bipolar androgen therapy and PD-1 inhibition in a patient with metastatic castration-resistant prostate cancer and a germline mutation.
Benjamin T Berger, Matthew K Labriola, Emmanuel S Antonarakis, Andrew J Armstrong

BMJ Case Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Foreign accent syndrome as a heralding manifestation of transformation to small cell neuroendocrine prostate cancer.
Amanda Broderick, Matthew K Labriola, Neal Shore, Andrew J Armstrong

BMJ Case Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission of progressive metastatic castration-resistant prostate cancer during abiraterone therapy following unilateral adrenalectomy for a functioning adrenal adenoma.
Katelyn Nazaneen Seale, Matthew K Labriola, Xiaoyin Sara Jiang, Andrew Armstrong

BMJ Case Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma.
Landon C Brown, Jason Zhu, Kunal Desai, Emily Kinsey, Chester Kao, Matthew K Labriola

J Immunother Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer.
Vadim S Koshkin, Vaibhav G Patel, Alicia Ali, Mehmet A Bilen, Deepak Ravindranathan, Matthew Labriola

Prostate Cancer Prostatic Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How we manage grief.
Anthony N Galanos, Matthew K Labriola

Clin Adv Hematol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setting a new standard for long-term survival in metastatic kidney cancer.
Matthew K Labriola, Daniel J George

Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
Maitri Kalra, Elizabeth Henry, Kelly McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Matthew K Labriola

JMIR Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies.
Matthew K Labriola, Saad Atiq, Nathan Hirshman, Rhonda L Bitting

Prostate Cancer Prostatic Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.
Landon C Brown, Matthew D Tucker, Ramy Sedhom, Eric B Schwartz, Jason Zhu, Matthew K Labriola

J Immunother Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Toxicity and Outcomes in Clinical Trial Participants From Minority Populations.
Matthew Labriola, Daniel J George

Am Soc Clin Oncol Educ Book· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma.
Landon C Brown, Jason Zhu, Matthew K Labriola, Yuan Wu, Sachica Cheris

Clin Genitourin Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients.
Tian Zhang, Sarabjot Pabla, Felicia L Lenzo, Jeffrey M Conroy, Mary K Nesline, Matthew Labriola

Oncoimmunology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma.
Matthew Kyle Labriola, Jason Zhu, Rajan T Gupta, Shannon McCall, Jennifer Jackson

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma.
Matthew K Labriola, Kristen A Batich, Jason Zhu, Megan A McNamara, Michael R Harrison

Clin Genitourin Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis